Bleeding caused by portal hypertension

Area of Science:

• Gastroenterology
• Hepatology
• Internal Medicine

Background:

• Variceal bleeding is a serious complication of portal hypertension, often seen in patients with cirrhosis.
• Early detection of gastro-esophageal varices via endoscopy is crucial for risk stratification.

Purpose of the Study:

• To outline diagnostic and therapeutic strategies for managing gastro-esophageal varices and preventing variceal bleeding.
• To discuss primary and secondary prophylaxis options for patients with cirrhosis and portal hypertension.

Main Methods:

• Diagnostic upper endoscopy for variceal detection.
• Pharmacological treatment with non-selective beta-blockers (propranolol, nadolol) titrated to heart rate.
• Endoscopic therapy, primarily banding, for prophylaxis and acute bleeding management.
• Resuscitation and vasoactive agents for acute GI bleeding.
• Transjugular intrahepatic portosystemic shunt (TIPS) for refractory cases.

Main Results:

• Non-selective beta-blockers are first-line treatment for medium-to-large varices.
• Prophylactic banding is an alternative for patients intolerant to beta-blockers.
• Acute bleeding management involves resuscitation, octreotide, and prompt endoscopy with banding.
• Combined pharmacological and endoscopic therapy is common for secondary prophylaxis.
• TIPS offers an effective option for refractory variceal bleeding.

Conclusions:

• Effective management of variceal bleeding relies on timely diagnosis and a multi-modal approach.
• Primary and secondary prophylaxis are essential to reduce rebleeding risk in patients with portal hypertension and cirrhosis.
• Treatment strategies should be individualized based on patient tolerance and disease severity.